Botulinum neurotoxin, commonly referred to as Botox, is a highly toxic neurotoxin produced by the bacterium Clostridium botulinum. It is most commonly used in medical and cosmetic procedures to temporarily relax muscles that are causing wrinkles in the face and neck. In addition to these aesthetics treatments, botulinum neurotoxin has also shown promise in treating certain physical ailments such as muscle spasms, stiff or weak muscles, migraine headaches, excessive sweating, and various forms of chronic pain. The neurotoxin blocks the release of acetylcholine, a neurotransmitter responsible for stimulating muscles, by binding to specific receptors on the nerve cells. This results in muscle paralysis, often leading to a reduction in the severity of wrinkles present on the face and neck. In the medical field, botulinum neurotoxin has been used to treat conditions such as dystonia, cerebral palsy, and spasticity. In treating medical ailments, the concentrated amounts of botulinum toxin can cause paralysis, allowing the body to repair and heal damaged muscles, without the need for invasive surgeries. In addition to aesthetics and medical treatments, botulinum neurotoxin has also been utilized to treat certain neurological diseases. Critically ill patients with certain types of brain injuries can benefit from the injection of botulinum toxin as it helps to reduce spasticity and other types of movements that can worsen the patient’s condition. Due to its toxicity, botulinum neurotoxin is regulated in numerous countries and the drug is typically supplied in specific vials for medical use. Therefore, it is important to reiterate that Botox should only be administered by licensed and experienced medical professionals. In addition to the potential side effects of the drug, misuse of botulinum toxin carries the risk of releasing toxins in the body’s nervous system, leading to irreversible neurological damage. As a result, it is essential to be aware of the risks and benefits associated with the use of botulinum neurotoxin.
Title : Perception and individuality
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : ACE-dependent Alzheimer’s Disease (AD)
Sergei M Danilov, University of Illinois, United States
Title : Essential roles, mechanisms and consequences of vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Neuroimaging by evaluation nerverenovate and neuroplasticity of acupuncture in children with cerebral palsy
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : The foundation and architecture of Personalized & Precision Medicine (PPM) in clinical neurology: Towards curative and neurodegenerative disease-modifying treatment for multiple sclerosis
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : Who cares …… for the carers
Jaqueline Tuppen, COGS Club, United Kingdom